MJ Biotech, Inc. Zen Tea House Increased Sales
CHEYENNE, Wyo., Feb. 27, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced today that Zen Hero, Inc. DBA Zen’s Tea House closed 2017 with sales of over $1,200,000 unaudited; a major threshold for a business that was founded in 2012.
Zen Hero, Inc, DBA Zen’s Tea House, founded in 2012, is a Southern California based manufacturing-retailer that specializes in Loose Leaf Botanical Nutraceuticals. Zen's Tea House works in cooperation with licensed Nutritionists, Naturopathic Physicians and holistic medical practitioners to create beneficial herbal remedies. Many people use these blends as an organic alternative. The rising demand for these Nutraceuticals has created a robust growth in multi-channel retail outlets, establishing Zen's Tea House as a leading tea and herb retailer in Southern California. Zen's Tea House creates proprietary blends for Doctors and their patients, while maintaining a wide assortment of Teas and Herbs available for public consumption.
Zen’s Tea House primarily operates in Farmers Markets, and Private Events and with independent retail Health Food outlets. Zen’s Tea House founder, Fernando Lopez, is well respected in the holistic nutraceutical industry and is the primary developer of the company’s proprietary blends of Teas and Herbs. Zen’s Tea House today operates in over 40 Farmers Markets and expects to increase its distribution with an additional 20 markets over the next 12 months.
Meet Fernando Lopez the COO of MJ Biotech and President of Zen Tea House. Additional information is available via Facebook at https://www.facebook.com/zensteahouse.
MJ Biotech will be holding an investor conference call within a few weeks and requests shareholders and potential investors to send questions to email@example.com ; all questions selected for the investor conference will be posed to MJ Biotech management and the inquirers will receive a free sample of Golden Milk, which is Zen’s Top selling proprietary blend.
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason.
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news
Upcoming Life Sciences Events
- September 2018
- Boston: Discovery on Target, DOT
- Pudong Xinqu: Tumor Models Shanghai
- Brussels: The Pharma Business Development Course - An Overview Course